Alzheimer’s disease – CFN Media

Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease

VANCOUVER, British Columbia, September 27, 2023–(BUSINESS WIRE)–Alpha Cognition Inc. (CSE: ACOG) (OTCQB:…

Ryan Allway
September 27, 2023

IGC Reports Financial Results for Fiscal Year Ended March 31, 2023

POTOMAC, Md., July 12, 2023–(BUSINESS WIRE)–IGC Pharma, Inc. (“IGC” or the “Company”)…

Ryan Allway
July 12, 2023

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

How to Invest in the LFP Electric Battery Boom

All electric cars, whether fully electric or hybrid, need some form of…

Robin Lefferts
November 6, 2024

Top News

Introducing LEEF Brands, Vertically Integrated California Powerhouse

The cannabis industry has fallen out of favor with many investors, in…

Ryan Allway
November 1, 2024

Aduro Clean Technologies Reports Fiscal 2025 First Quarter Results

LONDON, Ontario, Oct. 31, 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies…

Ryan Allway
October 31, 2024

CEO.CA Interviews Stallion Uranium CEO

Stallion Uranium Corp. (TSX.V: STUD) (OTCQB: STLNF) (FSE: FE0) CEO Drew Zimmerman…

Ryan Allway
October 29, 2024